Conditions: Perennial Allergic Rhinitis
Keywords: allergy
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 41
Healthy volunteers: no

Brief summary:
The purpose of this study is to see if a nasal steroid drug delivered to the nose with the NasoNeb™ inhaler improves the symptoms of people with perennial allergic rhinitis (year round allergy symptoms).

Detailed description:

Arms:
arm 1: Pulmicort Respules at a dose of 0.25 mg. delivered intranasally via NasoNeb nebulizer once daily arm 2: Placebo delivered intranasally via NasoNeb nebulizer once daily

Interventions: intervention 1: Budesonide intervention 2: Placebo
Intervention descriptions: intervention 1: Pulmicort Respules at a dose of 0.25 mg. delivered intranasally via NasoNeb nebulizer once daily intervention 2: Placebo delivered intranasally via NasoNeb nebulizer once daily

Protocol document: